MARKET

VNRX

VNRX

Volitionrx
AMEX
1.330
-0.060
-4.32%
Opening 12:08 06/09 EDT
OPEN
1.420
PREV CLOSE
1.390
HIGH
1.435
LOW
1.300
VOLUME
252.50K
TURNOVER
--
52 WEEK HIGH
18.80
52 WEEK LOW
1.300
MARKET CAP
11.47M
P/E (TTM)
-0.3149
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 1d ago
Weekly Report: what happened at VNRX last week (0601-0605)?
Weekly Report · 1d ago
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
Benzinga · 4d ago
VolitionRx files patent covering Nu.Q technology for Ebola triage
TipRanks · 6d ago
VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring
PR Newswire · 6d ago
Weekly Report: what happened at VNRX last week (0525-0529)?
Weekly Report · 06/01 09:22
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
PR Newswire · 05/27 12:17
More
About VNRX
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Webull offers VolitionRX Ltd stock information, including AMEX: VNRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNRX stock methods without spending real money on the virtual paper trading platform.